EchoCath begins selling ColorMark ultrasound imager
This article was originally published in Clinica
Executive Summary
EchoCath announced its first "meaningful revenue derived from the sale of its products". In the third quarter ending May 31, the company earned $142,000, from sales of its ColorMark system. This is used in the image enhancement of devices in ultrasound procedures and the licensing of other EchoCath technology.